UniProt P01258
Calcitonin (P01258)
Calcitonin (UniProt P01258): 6 experimental structures and 1 predicted model on GenesisL1, 1 ligand bound, 3 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P01258
- Protein
- Calcitonin
- Experimental structures
- 6
- Predicted models
- 1
- Ligands
- 1
- Pockets
- 3 · 2 records with a druggable one
Structures
7 records of P01258 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2JXZ | Solution Conformation of A Non-Amyloidogenic Analogue of Human Calcitonin in Sodium Dodecyl Sulfate… | solution nmr | A | — | — |
| 2JXZ | Solution conformation of a non-amyloidogenic analogue of human calcitonin in sodium dodecyl sulfate… | solution nmr | A | — | — |
| 7TYH | Human Amylin2 Receptor in complex with Gs and human calcitonin peptide | electron microscopy | P | — | 2 (best 0.75) |
| 7TYH | Human AMYLIN2 receptor in complex with gs and human calcitonin peptide | electron microscopy | P | NH2 | — |
| 7TYO | Calcitonin receptor in complex with Gs and human calcitonin peptide | electron microscopy | P | — | 1 (best 0.74) |
| 7TYO | Calcitonin receptor in complex with gs and human calcitonin peptide | electron microscopy | P | NH2 | — |
| P01258 | AlphaFold monomer V2.0 prediction for calcitonin (P01258) | predicted | A | — | — |
Ligands
- NH2 · Amino group · in 2 records
Experiment against prediction
- 2JXZ chain A against the predicted model P01258: TM-score 0.62, RMSD 1.08 Å
- 2JXZ chain A against the predicted model P01258: TM-score 0.62, RMSD 1.08 Å
- 7TYH chain P against the predicted model P01258: TM-score 0.48, RMSD 2.09 Å
- 7TYH chain P against the predicted model P01258: TM-score 0.48, RMSD 2.09 Å
- 7TYO chain P against the predicted model P01258: TM-score 0.43, RMSD 2.49 Å
- 7TYO chain P against the predicted model P01258: TM-score 0.43, RMSD 2.49 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.